Ardelyx reported $82.84M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Amgen USD 6.17B 624M Jun/2025
Ardelyx USD 82.84M 15.02M Jun/2025
Corcept Therapeutics USD 191M 36.19M Jun/2025
Life Technologies -15380000 1.88M Jun/2025
Sanofi EUR 7.74B 2.38B Jun/2025
TG Therapeutics USD 122.21M 16.9M Jun/2025
United Therapeutics USD 711M 9.1M Jun/2025